Evidence map›Paper›PMID 27613541›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2017

Influence of blood-brain barrier permeability on O-(2-

Carina Stegmayr, Ulrike Bandelow, Dennis Oliveira, Philipp Lohmann, Antje Willuweit, Christian Filss, Norbert Galldiks, Joachim H R Lübke, N Jon Shah, Johannes Ermert and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. The confounding effects of microvascular physiology on the uptake and diagnostic accuracy of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
  3. Article
  4. Radiosynthesis and biological evaluation of [European journal of nuclear medicine and molecular imaging · 2024
    Article
  5. Review
  6. Article
  7. Nuclear Medicine Imaging Procedures in Oncology.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  8. High uptake ofEJNMMI research · 2020
    Article
  9. Review
  10. Article
  11. Article
  12. Influence of Dexamethasone on O-(2-[Molecular imaging and biology · 2019
    Article
  13. Article
  14. Investigation of cis-4-[Molecular imaging and biology · 2018
    Article
  15. The Emerging Role of Amino Acid PET in Neuro-Oncology.Bioengineering (Basel, Switzerland) · 2018
    Review
  16. European research trends in nuclear medicine.Annals of nuclear medicine · 2018
    Review
  17. Hybrid MR-PET of brain tumours using amino acid PET and chemical exchange saturation transfer MRI.European journal of nuclear medicine and molecular imaging · 2018
    Article
  18. The British journal of radiology · 2018
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Carina StegmayrForschungszentrum Jülich, Institute of Neuroscience and Medicine, D-52425, Jülich, Germany. c.stegmayr@fz-juelich.de.
Ulrike BandelowForschungszentrum Jülich, Institute of Neuroscience and Medicine, D-52425, Jülich, Germany.
Dennis OliveiraForschungszentrum Jülich, Institute of Neuroscience and Medicine, D-52425, Jülich, Germany.
Philipp LohmannForschungszentrum Jülich, Institute of Neuroscience and Medicine, D-52425, Jülich, Germany.
Antje WilluweitForschungszentrum Jülich, Institute of Neuroscience and Medicine, D-52425, Jülich, Germany.
Christian FilssForschungszentrum Jülich, Institute of Neuroscience and Medicine, D-52425, Jülich, Germany.
Norbert GalldiksForschungszentrum Jülich, Institute of Neuroscience and Medicine, D-52425, Jülich, Germany.
Joachim H R LübkeForschungszentrum Jülich, Institute of Neuroscience and Medicine, D-52425, Jülich, Germany.
N Jon ShahForschungszentrum Jülich, Institute of Neuroscience and Medicine, D-52425, Jülich, Germany.
Johannes ErmertForschungszentrum Jülich, Institute of Neuroscience and Medicine, D-52425, Jülich, Germany.
Karl-Josef LangenForschungszentrum Jülich, Institute of Neuroscience and Medicine, D-52425, Jülich, Germany. k.j.langen@fz-juelich.de.
Forschungszentrum Jülich · DERWTH Aachen University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeO-(2-

methodsF98 glioma, 9L gliosarcoma or human U87 glioblastoma cells were implanted into the striatum of 56 Fischer or RNU rats. Thereafter, animals were divided into a control group and a group receiving injections of the glucocorticoid dexamethasone (Dex). After 12-13 days of tumor growth animals received injection of Evans blue dye (EBD) to visualize BBB disturbance and underwent

resultsIn Dex treated animals EBD extravasation was significantly reduced in 9L (P < 0.001) and U87 (P = 0.008) models and showed a trend in F98 models (P = 0.053). In contrast, no significant differences of

conclusionDespite a considerable reduction of BBB permeability in rat gliomas after Dex treatment, no relevant changes of

Indexed as

Capillary PermeabilityAnimalsAntineoplastic Agents, HormonalBlood-Brain BarrierCell Line, TumorDexamethasoneGliomaHumansMaleRadiopharmaceuticalsRatsTight JunctionsTyrosine(18F)fluoroethyltyrosineAntineoplastic Agents, HormonalDexamethasoneRadiopharmaceuticalsTyrosineBlood brain barrier (BBB)Brain tumorsDexamethasoneO-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET)PET

Identifiers

PMID27613541
OpenAlexW2515181145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.